Chinese Journal of Dermatology ›› 2021, Vol. 54 ›› Issue (10): 924-927.doi: 10.35541/cjd.20191116
• Reviews • Previous Articles Next Articles
Shao Lili, Liu Quanzhong
Received:
2019-11-26
Revised:
2020-07-12
Online:
2021-10-15
Published:
2021-09-28
Contact:
Liu Quanzhong
E-mail:liuqztjykdxzyy@163.com
Supported by:
Shao Lili, Liu Quanzhong. Phage therapy and its application and prospects in skin and genitourinary tract infections[J].Chinese Journal of Dermatology, 2021, 54(10): 924-927.
[1] | Lee AS, de Lencastre H, Garau J, et al. Methicillin⁃resistant Staphylococcus aureus[J]. Nat Rev Dis Primers, 2018,4:18033. doi: 10.1038/nrdp.2018.33. |
[2] | Luepke KH, Suda KJ, Boucher H, et al. Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications[J]. Pharmacotherapy, 2017,37(1):71⁃84. doi: 10.1002/phar.1868. |
[3] | Jamal M, Bukhari S, Andleeb S, et al. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields[J]. J Basic Microbiol, 2019,59(2):123⁃133. doi: 10.1002/jobm.201800412. |
[4] | Chanishvili N. Phage therapy⁃⁃history from Twort and d′Herelle through Soviet experience to current approaches[J]. Adv Virus Res, 2012,83:3⁃40. doi: 10.1016/B978⁃0⁃12⁃394438⁃2.00001⁃3. |
[5] | Sulakvelidze A, Alavidze Z, Morris JG Jr. Bacteriophage therapy.Antimicrob Agents Chemother, 2001,45(3):649⁃659. doi: 10. 1128/AAC.45.3.649⁃659.2001. |
[6] | Almeida GM, Leppänen M, Maasilta IJ, et al. Bacteriophage imaging: past, present and future[J]. Res Microbiol, 2018,169(9):488⁃494. doi: 10.1016/j.resmic.2018.05.006. |
[7] | 安瑞. 噬菌体治疗的前世、今生与未来——对话微生物学界噬菌体专家[J]. 科学通报, 2017,62(23):2577⁃2580. |
[8] | Nilsson AS. Phage therapy⁃⁃constraints and possibilities[J]. Ups J Med Sci, 2014,119(2):192⁃198. doi: 10.3109/03009734.2014. 902878. |
[9] | Kutateladze M, Adamia R. Bacteriophages as potential new therapeutics to replace or supplement antibiotics[J]. Trends Biotechnol, 2010,28(12):591⁃595. doi: 10.1016/j.tibtech.2010.08. 001. |
[10] | Weber⁃Dabrowska B, Mulczyk M, Górski A. Bacteriophage therapy of bacterial infections: an update of our institute′s experience[J]. Arch Immunol Ther Exp (Warsz), 2000,48(6):547⁃551. |
[11] | Jault P, Leclerc T, Jennes S, et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double⁃blind phase 1/2 trial. Lancet Infect Dis, 2019,19(1):35⁃45. doi:10.1016/S1473⁃3099(18)30482⁃1. |
[12] | Morozova VV, Vlassov VV, Tikunova NV. Applications of bacteriophages in the treatment of localized infections in humans[J]. Front Microbiol, 2018,9:1696. doi: 10.3389/fmicb. 2018.01696. |
[13] | Markoishvili K, Tsitlanadze G, Katsarava R, et al. A novel sustained⁃release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds[J]. Int J Dermatol, 2002,41(7):453⁃458. doi:10.1046/j.1365⁃4362.2002.01451.x |
[14] | Rhoads DD, Wolcott RD, Kuskowski MA, et al. Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial[J]. J Wound Care, 2009,18(6):237⁃238,240⁃243. doi: 10.12968/jowc.2009.18.6.42801. |
[15] | Morozova VV, Kozlova YN, Ganichev DA, et al. Bacteriophage treatment of infected diabetic foot ulcers[J]. Methods Mol Biol, 2018,1693:151⁃158. doi: 10.1007/978⁃1⁃4939⁃7395⁃8_13. |
[16] | Fish R, Kutter E, Wheat G, et al. Compassionate use of bacteriophage therapy for foot ulcer treatment as an effective step for moving toward clinical trials[J]. Methods Mol Biol, 2018,1693:159⁃170. doi: 10.1007/978⁃1⁃4939⁃7395⁃8_14. |
[17] | Totté J, van Doorn MB, Pasmans S. Successful Treatment of Chronic Staphylococcus aureus⁃related dermatoses with the topical endolysin Staphefekt SA.100: a report of 3 cases[J]. Case Rep Dermatol, 2017,9(2):19⁃25. doi: 10.1159/000473872. |
[18] | van Bijnen EM, Paget WJ, den Heijer CD, et al. Primary care treatment guidelines for skin infections in Europe: congruence with antimicrobial resistance found in commensal Staphylococcus aureus in the community[J]. BMC Fam Pract, 2014,15:175. doi: 10.1186/s12875⁃014⁃0175⁃8. |
[19] | 首例超级细菌感染患者经噬菌体治疗痊愈[EB/OL]. [2019⁃05⁃25]. http://www.sh.chinanews.com/yljk/2018⁃08⁃15/43418.shtml. |
[20] | Kuipers S, Ruth MM, Mientjes M, et al. A Dutch case report of successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant patient[J]. Antimicrob Agents Chemother, 2019,64(1):e01281⁃19. doi: 10. 1128/AAC. 01281⁃19. |
[21] | Rostkowska OM, Międzybrodzki R, Miszewska⁃Szyszkowska D, et al. Treatment of recurrent urinary tract infections in a 60⁃year⁃old kidney transplant recipient. The use of phage therapy[J]. Transpl Infect Dis, 2020:e13391. doi: 10.1111/tid.13391. |
[22] | Leitner L, Sybesma W, Chanishvili N, et al. Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo⁃controlled, double⁃blind clinical trial[J]. BMC Urol, 2017,17(1):90. doi: 10.1186/s12894⁃017⁃0283⁃6. |
[23] | Zalewska⁃Piątek B, Piątek R. Phage therapy as a novel strategy in the treatment of urinary tract infections caused by E. Coli[J]. Antibiotics (Basel), 2020,9(6):304. doi: 10.3390/antibiotics906 0304. |
[24] | Bhattarai SR, Yoo SY, Lee SW, et al. Engineered phage⁃based therapeutic materials inhibit Chlamydia trachomatis intracellular infection[J]. Biomaterials, 2012,33(20):5166⁃5174. doi: 10.1016/ j.biomaterials.2012.03.054. |
[25] | 练婷婷, 魏世娟, 刘原君, 等. M13⁃IN5重组噬菌体的构建与鉴定及其对沙眼衣原体的作用研究[J]. 中华皮肤科杂志,2018,51(12):859⁃864. doi: 10.3760/cma.j.issn.0412⁃4030.2018. 12.002. |
[1] | Wang Yifei, Geng Yi, Miao Qiuju, Song Hao, Xu Xiulian, Sun Jianfang. Clinicopathological analysis of ten cases of mucinous nevi [J]. Chinese Journal of Dermatology, 2021, 54(9): 804-807. |
[2] | Long Hai, Jiang Li, Qiu Yueqi, Yao Nan, Liu Licong, Xie Yuming, Xiong Feng, Tan Siqi, Kuang Qiqi, You Ruixuan, Chai Ke, Luo Xin, Long Haojun, Xin Yue, Guo Ziyu, Wang Jiaqi, Tan Yixin, Zhang Qing, Zhang Guiying, Li Yaping, Su Yuwen, Xiao Rong, Lu Qianjin, . Clinical analysis of 1 057 patients with critical illnesses in a dermatological ward [J]. Chinese Journal of Dermatology, 2021, 54(9): 790-797. |
[3] | Qiu Yueqi, Fu Siqi, Luo Shuaihantian, Li Yaping, Zhang Guiying. Research advance in androgenetic alopecia in 2020 [J]. Chinese Journal of Dermatology, 2021, 54(9): 835-838. |
[4] | Autoimmune Disease Group, China Dermatologist Association. Chinese expert consensus on cyclophosphamide for the treatment of autoimmune dermatoses [J]. Chinese Journal of Dermatology, 2021, 54(9): 765-770. |
[5] | Laser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Cosmetic Laser Group, Chinese Society of Dermatology, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association. Consensus on treatment of acne scars in China (2021) [J]. Chinese Journal of Dermatology, 2021, 54(9): 747-756. |
[6] | Zhang Xiao, Fu Meng, Wang Lei, Liu Yu, Gao Tianwen, Liu Ling. Analysis of 118 cases of clinically misdiagnosed cutaneous melanoma [J]. Chinese Journal of Dermatology, 2021, 54(9): 771-776. |
[7] | Wu Yuhao, Zhang Guolong, Wang Xiuli. Tertiary lymphoid structures in malignant melanoma [J]. Chinese Journal of Dermatology, 2021, 54(9): 827-830. |
[8] | Liu Qian, Li Guohong, Chen Bingwei. A survey on quality of life and its influencing factors among patients with non-melanoma skin cancers [J]. Chinese Journal of Dermatology, 2021, 54(9): 819-821. |
[9] | Chen Fengming, Kang Hanmei, Gao Tianwen, Fu Meng, Wang Lei, Liu Ling. Clinicopathological features of 10 cases of congenital melanocytic nevi complicated by proliferative nodules [J]. Chinese Journal of Dermatology, 2021, 54(9): 785-789. |
[10] | Wang Daguang, Jiang Jiayi. Considerations in the diagnosis and treatment of several nail diseases [J]. Chinese Journal of Dermatology, 2021, 54(8): 733-737. |
[11] | Li Ting, Xu Mingyuan, Wu Fei, Liang Yulin, Liu Yeqiang. Histopathological and clinical analysis of 204 patients with cutaneous horns [J]. Chinese Journal of Dermatology, 2021, 54(8): 677-682. |
[12] | Hu Feng, Chen Liuqing, Wang Wei, Zheng Fang. Epidemiological characteristics and disease spectrum analysis of outpatients in the dermatology department of a hospital in Wuhan during the COVID-19 epidemic [J]. Chinese Journal of Dermatology, 2021, 54(8): 719-722. |
[13] | Skin Tumor Research Center, Chinese Society of Dermatology, Subcommittee on Skin Tumor, China Dermatologist Association. Consensus on diagnosis and treatment of cutaneous squamous cell carcinoma (2021) [J]. Chinese Journal of Dermatology, 2021, 54(8): 653-664. |
[14] | Chen Yingdan, Huang Hui, Luo Shuaihantian, Li Yaping, Shi Xiaoliu, Zhang Guiying. A case of atypical late-onset Netherton syndrome without bamboo hair [J]. Chinese Journal of Dermatology, 2021, 54(8): 716-718. |
[15] | Yang Min, Chang Jianmin. Imatinib-induced cutaneous adverse reactions [J]. Chinese Journal of Dermatology, 2021, 54(8): 738-741. |
|